NCT07466238 2026-04-08
HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer
Peking University
Phase NA Recruiting
Clinical Trials
11 trialsNCT03514368 2026-02-19
MINER
Institut Claudius Regaud
Phase NA Recruiting
NCT06190275 2026-01-21
Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors
Grit Biotechnology
Phase NA Recruiting
NCT06248554 2025-12-02
Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation
Tongji Hospital
Phase NA Recruiting
NCT06740370 2025-08-14
TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma
Sun Yat-sen University
Phase NA Recruiting
NCT05754203 2025-07-14
Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC
Xinqiao Hospital of Chongqing
Phase NA Recruiting
NCT06622031 2025-01-13
TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT
Sun Yat-sen University
Phase NA Recruiting
NCT06752044 2024-12-30
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
The First Affiliated Hospital of Nanchang University
Phase NA Recruiting
NCT06752057 2024-12-30
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
The First Affiliated Hospital of Nanchang University
Phase NA Recruiting
NCT06702566 2024-11-25
The Effect of Serum Ferritin in irAE
Tianjin Medical University Cancer Institute and Hospital
Phase NA Recruiting
NCT05878977 2024-10-18
Biomarkers in Immunotherapy of Melanoma
Institute of Oncology Ljubljana
Phase NA Recruiting